Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Primary Lymphoid Organs01:16

Primary Lymphoid Organs

14.3K
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
14.3K
Secondary Lymphoid Organs01:15

Secondary Lymphoid Organs

8.6K
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overall survival of patients with chronic lymphocytic leukemia treated with venetoclax-obinutuzumab compared to age- and sex-matched general population.

Leukemia & lymphoma·2026
Same author

Intramyocardial Dissecting Hematoma After Myocardial Infarction Diagnosed by Multimodality Imaging.

JACC. Case reports·2026
Same author

The release of clinical information under the 21st century cures act and implications for patients with cancer: a narrative review.

Annals of palliative medicine·2026
Same author

Immune-related adverse effects in palliative care clinic.

Annals of palliative medicine·2026
Same author

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Mayo Clinic Systematic Management and Risk-Adapted Therapy for Lymphoid Malignancies (lySMART) Consensus Guidelines 2026.

Mayo Clinic proceedings·2026
Same author

Patient-reported time toxicity with bispecific antibody therapies in relapsed/refractory follicular lymphoma and diffuse large B-cell lymphoma.

The oncologist·2026

Related Experiment Video

Updated: Dec 19, 2025

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.0K

On point in primary CNS lymphoma.

Mazie Tsang1, Joseph Cleveland2, James L Rubenstein1,3

  • 1Division of Hematology/Oncology, University of California, San Francisco, California, USA.

Hematological Oncology
|June 9, 2020
PubMed
Summary

Primary CNS lymphoma (PCNSL) is a challenging brain tumor. Advances in molecular diagnostics and targeted therapies show promise for improving treatment outcomes and overcoming drug resistance.

Keywords:
NFkBhigh dose chemotherapyimmunotherapyminimal residual diseaseprimary CNS lymphoma

More Related Videos

Author Spotlight: Unveiling Cellular Functions and Potential Clinical Implications of Leptomeningeal Lymphatic Endothelial Cells
06:44

Author Spotlight: Unveiling Cellular Functions and Potential Clinical Implications of Leptomeningeal Lymphatic Endothelial Cells

Published on: September 8, 2023

2.1K
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.6K

Related Experiment Videos

Last Updated: Dec 19, 2025

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking
11:39

Subcellular Fractionation of Primary Chronic Lymphocytic Leukemia Cells to Monitor Nuclear/Cytoplasmic Protein Trafficking

Published on: October 23, 2019

12.0K
Author Spotlight: Unveiling Cellular Functions and Potential Clinical Implications of Leptomeningeal Lymphatic Endothelial Cells
06:44

Author Spotlight: Unveiling Cellular Functions and Potential Clinical Implications of Leptomeningeal Lymphatic Endothelial Cells

Published on: September 8, 2023

2.1K
Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
09:01

Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis

Published on: November 17, 2020

7.6K

Area of Science:

  • Neuro-oncology
  • Hematology
  • Precision Medicine

Background:

  • Primary CNS lymphoma (PCNSL) is an aggressive brain tumor with complex pathogenesis.
  • Current treatment strategies face challenges in efficacy and minimizing toxicity.
  • Understanding the tumor microenvironment and resistance mechanisms is crucial.

Purpose of the Study:

  • To review current challenges and emerging strategies in PCNSL diagnosis and treatment.
  • To highlight the role of molecular diagnostics, imaging, and novel therapeutic agents.
  • To discuss the impact of the blood-brain barrier on treatment efficacy.

Main Methods:

  • Review of current literature on PCNSL diagnosis, treatment, and emerging technologies.
  • Analysis of early-phase clinical investigations of targeted agents.
  • Discussion of molecular pathways and tumor microenvironment factors.

Main Results:

  • The B-cell receptor (BCR) pathway, involving MYD88 and CD79B, is critical in PCNSL pathogenesis.
  • Ibrutinib and IMiD agents show promise, but resistance mechanisms require further study.
  • The blood-brain barrier remains a significant challenge for drug delivery.

Conclusions:

  • Molecular diagnostics and imaging are essential for refining treatment delivery and response assessment.
  • Targeting the BCR pathway and overcoming tumor immunosuppression are key therapeutic goals.
  • Innovative drug delivery strategies are needed to improve outcomes for PCNSL patients.